Now all we need is confirmation the FDA has approved our Nuvaring generic and we can sit back, or strap in, to $1?
Nuvaring worth about ~$1.1b USD. If we're the first generic to the market, i reckon we can take about 30-40% (obviously reducing price and therefore that $1.1b market, but still, even a 20-40% price reduction isn't bad), if we're 2nd-3rd, probably 10-15-20%.
The last time we received FDA approval i think i counted 6-7-8 weeks between approval and roll-out. The company said they expect approval this CY. That means a sustained and substantial growth rate is on our doorstep for years to come.
Just a guess, but~ $525m in sales last year. Nuvaring CY20 should add a couple hundred million to that, if we're first to market, probably only $100-$200m if we're second. Then comes Novel sales CY21...... And what was the worst case, ~$342m/PA...... Now add the 'strong growth' in MCS, women's health divisions and specialty brands (double digits right?), an improving generic market - as the competition is exposed for a number of questionable business practices - and, well.... This rally really is just beginning.
- Forums
- ASX - By Stock
- MYX
- Is MYX a bargain
Is MYX a bargain, page-327
-
- There are more pages in this discussion • 2,179 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
|
|||||
Last
$3.95 |
Change
0.120(3.13%) |
Mkt cap ! $336.0M |
Open | High | Low | Value | Volume |
$3.80 | $4.03 | $3.74 | $589.4K | 150.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 572 | $3.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.95 | 814 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 572 | 3.900 |
2 | 715 | 3.890 |
5 | 8915 | 3.880 |
1 | 143 | 3.870 |
1 | 143 | 3.860 |
Price($) | Vol. | No. |
---|---|---|
3.950 | 814 | 2 |
3.960 | 715 | 2 |
3.970 | 715 | 2 |
3.980 | 4804 | 4 |
3.990 | 143 | 1 |
Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |